SR One Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.3M | Hold |
3,127,933
| – | – | 9.17% | 6 |
|
|
2025
Q1 | $49.7M | Buy |
3,127,933
+1,111,111
| +55% | +$17.6M | 12.76% | 3 |
|
|
2024
Q4 | $24.8M | Hold |
2,016,822
| – | – | 6.05% | 6 |
|
|
2024
Q3 | $24.4M | Hold |
2,016,822
| – | – | 4.9% | 6 |
|
|
2024
Q2 | $23.6M | Hold |
2,016,822
| – | – | 7.39% | 5 |
|
|
2024
Q1 | $26M | Buy |
2,016,822
+222,222
| +12% | +$2.87M | 7.15% | 6 |
|
|
2023
Q4 | $15.4M | Hold |
1,794,600
| – | – | 6.48% | 4 |
|
|
2023
Q3 | $17.1M | Hold |
1,794,600
| – | – | 8.75% | 2 |
|
|
2023
Q2 | $30.6M | Hold |
1,794,600
| – | – | 13.19% | 3 |
|
|
2023
Q1 | $28.1M | Buy |
+1,794,600
| New | +$28.1M | 10.47% | 3 |
|